Advanced search
Publication Cover
Scandinavian Journal of Gastroenterology Volume 52, 2017 - Issue 8
Submit an article Journal homepage
515
Views
29
CrossRef citations to date
0
Altmetric
Original Article

The correlation between histological gastritis staging- ‘OLGA/OLGIM’ and serum pepsinogen test in assessment of gastric atrophy/intestinal metaplasia in China

Xiaoteng WangDepartment of Gastroenterology, First Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, PR China; ;Department of Gastroenterology, The First Hospital of Jiaxing, Jiaxing, PR China
,
Bin LuDepartment of Gastroenterology, First Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, PR China; Correspondence[email protected]
,
Lina MengDepartment of Gastroenterology, First Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, PR China;
,
Yihong FanDepartment of Gastroenterology, First Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, PR China;
,
Shuo ZhangDepartment of Gastroenterology, First Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, PR China;
&
Meng LiDepartment of Gastroenterology, First Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, PR China;
Pages 822-827 | Received 05 Feb 2017, Accepted 02 Apr 2017, Published online: 22 Apr 2017

References

  • Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136:E359–E386.
  • Ajani JA, Bentrem DJ, Besh S, et al. Gastric cancer, version 2.2013: featured updates to the NCCN Guidelines. J Natl Compr Canc Netw. 2013;11:531–546.
  • de Vries AC, Vall Gfieken NC, Looman CW, et al. GC risk in patients with premalignant gastric lesions: a nationwide cohort study in the Netherlands. Gastroenterology. 2008;134:945–952.
  • Rugge M, de Boni M, Pennelli G, et al. Gastritis OLGA-staging and gastric cancer risk: a twelve-year clinico-pathological follow-up study. Aliment Pharmacol Ther. 2010;31:1104–1111.
  • Rugge M, Meggio A, Pennelli G, et al. Gastritis staging in clinical practice: the OLGA staging system. Gut. 2007;56:631–636.
  • Capelle L, de Vries A, Haringsma J, et al. The staging of gastritis with the OLGA system by using intestinal metaplasia as an accurate alternative for atrophic gastritis. Gastrointest Endosc. 2010;71:1150–1158.
  • Rugge M, Fassan M, Pizzi M, et al. Operative link for gastritis assessment vs operative link on intestinal metaplasia assessment. WJG. 2011;17:4596–4601.
  • Kudo T, Kakizaki S, Sohara N, et al. Analysis of ABC (D) stratification for screening patients with gastric cancer. World J Gastroenterol. 2011;17:4793–4798.
  • Dixon MF, Genta RM, Yardley JH, et al. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol. 1996;20:1161–1181.
  • Chinese Society of Digestive Endoscopy. Early GC screening program in China. Chin J Dig Endosc. 2014;31:361--377.
  • Eybpoosh S, Talebkhan Y, Saberi S, et al. Age-specific gastric cancer risk indicated by the combination of Helicobacter pylori sero-status and serum pepsinogen levels. Iran Biomed J. 2015;19:133–142.
  • Watabe H, Mitsushima T, Yamaji Y, et al. Predicting the development of GC from combining Helicobacter pylori antibodies and serum pepsinogen status: a prospective endoscopic cohort study. Gut. 2005;54:764–768.
  • Daugule I, Sudraba A, Chiu HM, et al. Gastric plasma biomarkers and Operative Link for Gastritis Assessment gastritis stage. Eur J Gastroenterol Hepatol. 2011;23:302–307.
  • De Re V, Orzes E, Canzonieri V, et al. Pepsinogens to distinguish patients with gastric intestinal metaplasia and Helicobacter pylori infection among populations at risk for GC. Clin Trans Gastroenterol. 2016;7:e183–e121.
  • Cho SJ, Choi IJ, Kook MC, et al. Staging of intestinal- and diffuse-type gastric cancers with the OLGA and OLGIM staging systems. Aliment Pharmacol Ther. 2013;38:1292–1302.
  • Haj-Sheykholeslami A, Rakhshani N, Amirzargar A, et al. Serum pepsinogen I, pepsinogen II, and gastrin 17 in relatives of GC patients: comparative study with type and severity of gastritis. Clin Gastroenterol Hepatol. 2008;6:174–179.
  • Miki K, Urita Y. Using serum pepsinogens wisely in a clinical practice. J Dig Dis. 2007;8:8–14.
  • Malfertheiner P, Megraud F, O’Morain CA, et al. Management of Helicobacter pylori infection-the Maastricht IV/ Florence consensus report. Gut. 2012;61:646–664.
  • Miki K. Gastric cancer screening using the serum pepsinogen test method. Gastric Cancer. 2006;9:245–253.
  • Syrjanen K. A panel of serum biomarkers (GastroPanel®) in non-invasive diagnosis of atrophic gastritis. Systematic review and meta-analysis. Anticancer Res. 2016;36:5133–5144.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.